June 24, 2020
Osaka Univ. Prof. Sawa (left), Rohto Chairman Yamada Meet Press in Osaka Rohto Pharmaceutical said on June 23 that it will start a clinical trial in Japan in August for its allogenic mesenchymal stem cell (MSC) therapy for the treatment...read more